These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33384677)

  • 41. Chikungunya virus requires cellular chloride channels for efficient genome replication.
    Müller M; Slivinski N; Todd EJAA; Khalid H; Li R; Karwatka M; Merits A; Mankouri J; Tuplin A
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007703. PubMed ID: 31483794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate.
    Freire MCLC; Basso LGM; Mendes LFS; Mesquita NCMR; Mottin M; Fernandes RS; Policastro LR; Godoy AS; Santos IA; Ruiz UEA; Caruso IP; Sousa BKP; Jardim ACG; Almeida FCL; Gil LHVG; Andrade CH; Oliva G
    Sci Rep; 2022 Jun; 12(1):10601. PubMed ID: 35732685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of a Potent and Selective Chikungunya Virus Envelope Protein Inhibitor through Computer-Aided Drug Design.
    Battini L; Fidalgo DM; Álvarez DE; Bollini M
    ACS Infect Dis; 2021 Jun; 7(6):1503-1518. PubMed ID: 34048233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
    Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
    Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphorylation Sites in the Hypervariable Domain in Chikungunya Virus nsP3 Are Crucial for Viral Replication.
    Teppor M; Žusinaite E; Merits A
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33568506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya Virus: a drug repositioning approach.
    Agarwal G; Gupta S; Gabrani R; Gupta A; Chaudhary VK; Gupta V
    Bioinformation; 2019; 15(6):439-447. PubMed ID: 31312082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conserved motifs in the hypervariable domain of chikungunya virus nsP3 required for transmission by Aedes aegypti mosquitoes.
    Göertz GP; Lingemann M; Geertsema C; Abma-Henkens MHC; Vogels CBF; Koenraadt CJM; van Oers MM; Pijlman GP
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006958. PubMed ID: 30412583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
    Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
    J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. P38 and JNK Mitogen-Activated Protein Kinases Interact With Chikungunya Virus Non-structural Protein-2 and Regulate TNF Induction During Viral Infection in Macrophages.
    Nayak TK; Mamidi P; Sahoo SS; Kumar PS; Mahish C; Chatterjee S; Subudhi BB; Chattopadhyay S; Chattopadhyay S
    Front Immunol; 2019; 10():786. PubMed ID: 31031770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In silico identification and in vitro antiviral validation of potential inhibitors against Chikungunya virus.
    Verma J; Hasan A; Sunil S; Subbarao N
    J Comput Aided Mol Des; 2022 Jul; 36(7):521-536. PubMed ID: 35789450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suramin Inhibits Chikungunya Virus Entry and Transmission.
    Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC
    PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In silico study on anti-Chikungunya virus activity of hesperetin.
    Oo A; Hassandarvish P; Chin SP; Lee VS; Abu Bakar S; Zandi K
    PeerJ; 2016; 4():e2602. PubMed ID: 27812412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection.
    Albulescu IC; White-Scholten L; Tas A; Hoornweg TE; Ferla S; Kovacikova K; Smit JM; Brancale A; Snijder EJ; van Hemert MJ
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32191995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethyl palmitate, an anti-chikungunya virus principle from Sauropus androgynus, a medicinal plant used to alleviate fever in ethnomedicine.
    Sagna A; Nair RVR; Hulyalkar N; Rajasekharan S; Nair VTG; Sivakumar KC; Suja SR; Baby S; Sreekumar E
    J Ethnopharmacol; 2023 Jun; 309():116366. PubMed ID: 36914036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Dimeric Peptide (KKYRYHLKPF)
    Ayusso GM; Lima MLD; da Silva Sanches PR; Santos IA; Martins DOS; da Conceição PJP; Carvalho T; da Costa VG; Bittar C; Merits A; Santos-Filho NA; Cilli EM; Jardim ACG; de Freitas Calmon M; Rahal P
    Viruses; 2023 May; 15(5):. PubMed ID: 37243254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of Functional Determinants in the Chikungunya Virus E2 Protein.
    Weber C; Berberich E; von Rhein C; Henß L; Hildt E; Schnierle BS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005318. PubMed ID: 28114368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.
    Tong W; Yin XX; Lee BJ; Li YG
    Acta Virol; 2015 Jun; 59(2):189-93. PubMed ID: 26104337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery and development of labdane-oxindole hybrids as small-molecule inhibitors against chikungunya virus infection.
    Tran QTN; Lee RCH; Liu HJ; Ran D; Low VZL; To DQ; Chu JJH; Chai CLL
    Eur J Med Chem; 2022 Feb; 230():114110. PubMed ID: 35085859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.